CTSOVSHCA• 7 Days (Normalized)
CTSO vs HCA (Cytosorbents Corporation vs HCA Healthcare Inc.)
Showing Closing Date Range from Sep 28 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $3.97
-1.37%
Cytosorbents Corporation
Normalized Baseline0.00%
HCA Performance $434.92
+0.54%
HCA Healthcare Inc.
Normalized Baseline0.00%
Alpha Spread Margin HCA LEADS
-1.91 pts
HCA outperforming by 1.91 percentage points
CTSOHCA
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO HCA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | CTSO Price | CTSO Gain (%) | HCA Price | HCA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $3.97 | -1.37% | $434.92 | +0.54% | -1.91% |
| Oct 02, 2026 | $4.05 | +0.75% | $426.69 | -1.37% | +2.12% |
| Sep 30, 2026 | $3.90 | -2.99% | $430.43 | -0.50% | -2.49% |
| Sep 29, 2026 | $4.00 | -0.50% | $431.63 | -0.22% | -0.28% |
| Sep 28, 2026 | $4.02 | +0.00% | $432.60 | +0.00% | +0.00% |